ArticleScientific reports2026
Green synthesis nanocomposite GO/ZnFe
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Materials based on graphene oxide (GO) and zinc ferrite nanoparticles (ZnFe₂O₄ NPs) have attracted considerable attention due to their large surface area, structural versatility, and potential biological functionality. In this study, GO NPs, ZnFe₂O₄ NPs, and a GO/ZnFe₂O₄ nanocomposite (GO/ZnFe₂O₄ NC) were green-synthesized and systematically characterized, focusing on their structural, magnetic, optical, and biological properties. Structural and compositional features were analyzed using X-ray diffraction (XRD), Raman spectroscopy, energy-dispersive X-ray analysis (EDX), and vibrating sample magnetometry (VSM), while scanning electron microscopy (SEM) was employed to investigate the morphology of the materials. The antibacterial activity of the synthesized materials was evaluated against Escherichia coli and Staphylococcus aureus. Both ZnFe₂O₄ NPs and the GO/ZnFe₂O₄ NC exhibited notable antibacterial effects, with the nanocomposite showing superior inhibitory performance against both bacterial strains. Furthermore, the GO/ZnFe₂O₄ NC demonstrated significant cytotoxic activity against HeLa cancer cells, with an IC₅₀ value of 13.58 µg/mL, while exhibiting considerably lower toxicity toward normal fibroblast cells (IC₅₀ = 158.5 µg/mL), indicating selective anticancer potential. Gene expression analysis revealed that treatment with the GO/ZnFe₂O₄ NC significantly upregulated the pro-apoptotic genes BAX and Caspase-3, while markedly downregulating the anti-apoptotic gene Bcl-2, suggesting apoptosis as a possible mechanism underlying its cytotoxic effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.